Ethnicity and psychopharmacology: Bridging the gap

Psychiatric Clinics of North America

Volumn 18, Issue 3, 1995, Pages 635-647

  Lin, K M ^a   Anderson, D ^a   Poland, R E ^a  

^a Building B 4 South ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADINAZOLAM; BENZODIAZEPINE DERIVATIVE; DESIPRAMINE; DIAZEPAM; HALOPERIDOL; IMIPRAMINE; LITHIUM; NEUROLEPTIC AGENT; NORTRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CAUCASIAN; ETHNIC GROUP; HUMAN; MENTAL DISEASE; NEGRO; PHARMACODYNAMICS; PHARMACOGENETICS; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW;

EID: 0029098958     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0193-953x(18)30045-5     Document Type: Review

References (55)

1. Adams G. Dworkin R. Rosenberg S. Diagnosis and pharmacotherapy issues in the care of Hispanics in the public sector Am J Psychiatry 141 1984 970 974
2. Allen J. Rack P. Vaddadi K. Differences in the effects of clomipramine on English and Asian volunteers: Preliminary report on a pilot study Postgrad Med J 53 1977 79 86
3. Baumann P. Eap C. Alpha-acid Glycoprotein Genetics, Biochemistry, Physiological Functions and Pharmacology 1988 Alan R. Liss New York
4. Branch R. Salih S. Homeida M. Racial differences in drug metabolizing ability: A study with antipyrine in the Sudan Clin Pharmacol Ther 24 1978 283 286
5. Clark W. Brater D. Johnson A. Goth's Medical Pharmacology ed 12 1988 CV Mosby St. Louis
6. Crabtree B. Jann M. Pitts W. Alpha acid glycoprotein levels in patients with schizophrenia: Effect of treatment with haloperidol Biol Psychiatry 29 1991 43a 48a
7. Dimsdale J. Zeigler M. Graham R. The effect of hypertension, sodium, and race on isoproterenol sensitivity Clin Exp Hypertens [A] 10 1988 747 756
8. Escobar J. Tuason V. Antidepressant agents: A cross cultural study Psychopharmacol Bull 16 1980 49 52
9. Fraser H. Mucklow J. Bulpitt C. Environmental factors affecting antipyrine metabolism in London factory and office workers Br J Clin Pharmacol 7 1979 237 243
10. Garde J. Aston R. Endler G. Racial mydriatic response to belladonna premedication Anesth Analg 57 1978 572 576
11. Gaviria M. Gill A. Javaid J. Nortriptyline kinetics in Hispanic and Anglo subjects J Clin Psychopharmacol 6 1986 227 231
12. Goldberg S. Schooler N. Davidson E. Sex and race differences in response to drug treatment among schizophrenics Psychopharmacologia (Berlin 9 1966 31 47
13. Goldstein J.A. Faletto M.B. Romkes-Sparks M. Evidence that CPY2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans Biochemistry 33 1994 1743 1752
14. Greenblatt D. Basic pharmacokinetic principles and their application to psychotropic drugs J Clin Psychiatry 54 1993 8 13 (suppl
15. Harding T.W. Chrusciel T.L. The use of psychotropic drugs in developing countries Bull World Health Organ 52 1975 359 367
16. Jann M. Lam Y. Chang W. Haloperidol and reduced haloperidol plasma concentrations in different ethnic populations and interindividual variabilities in haloperidol metabolism Lin K. Poland R. Nakasaki G. Psychopharmacology and Psychobiology of Ethnicity 1993 American Psychiatric Press Washington 133 152
17. Juneja R. Weitkamp L. Straitil A. Further studies of the plasma, alpha B-glycoprotein polymorphism: Two new alleles and allele frequencies in Caucasians and in American Blacks Hum Hered 38 1988 267 272
18. Kalow W. Race and therapeutic drug response New Engl J Med 320 1989 588 589
19. Kalow W. Interethnic variation of drug metabolism Trends Pharmacol Sci 12 1991 102 107
20. Kalow W. Pharmacogenetics of Drug Metabolism 1992 Pergamon Press New York
21. Kalow W. Pharmacogenetics: Its biologic roots and the medical challenge Clin Pharmacol Ther 54 1993 235 241
22. Kleinman A. Rethinking Psychiatry 1988 Free Press New York
23. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin Pharmacol Rev 33 1981 1 53
24. Kremer J. Wilting J. Janssen L. Drug binding to human alpha-l-acid glycoprotein in health and disease Pharmacol Rev 40 1988 1 45
25. Kumana C. Lauder I. Chan M. Differences in diazepam pharmacokinetics in Chinese and White Caucasians-Relation to body lipid stores Eur J Clin Pharmacol 32 1987 211 215
26. Levy R. Moreland T. Rationale for monitoring free drug levels Clin Pharmacokinet l 1984 (suppl
27. Lin K. Poland R. Nakasaki G. Psychopharmacology and Psychobiology of Ethnicity 1993 American Psychiatric Press Washington
28. Lin K. Poland R. Lau J. Haloperidol and prolactin concentrations in Asians and Caucasians J Clin Psychopharmacol 8 1988 195 201
29. Lin K. Poland R. Nuccio I. Longitudinal assessment of haloperidol dosage and serum concentration in Asian and Caucasian schizophrenic patients Am J Psychiatry 146 1989 1307 1311
30. Lin K. Poland R. Smith M. Pharmacokinetic and other related factors affecting psychotropic responses in Asians Psychopharmacol Bull 27 1991 427 439
31. Lu F.G. Chien C.P. Heming G. Ethnicity and neuroleptic drug dosage 1987 Chicago New research poster presentation at the Annual Meeting of the American Psychiatric Association May 12
32. Marcolin M. Stiers W. Chung Y. Racial differences in schizophrenia when controlling for economic status Paper presented at the Annual Meeting of the American Psychiatric Association, New Orleans 1991 May 11-16
33. Mendoza R. Smith M. Poland R. Ethnic psychopharmacology: The Hispanic and Native American perspective Psychopharmacol Bull 27 1991 449 461
34. Midha K. Hawes E. Hubbard J. Variation in the single dose pharmacokinetics of fluphenazine in psychiatric patients Psychopharmacology 96 1988 206 211
35. Midha K. Hawes E. Hubbard J. A pharmacokinetic study of trifluoperazine in two ethnic populations Psychopharmacology 95 1988 333 338
36. Okey A. Enzyme Induction in the Cytochrome P-450 System 1992 Pergamon Press New York
37. Olatawara M. The effects of psychotropic drugs in different populations Bull World Health Organ 56 1978 519 523
38. Potkin S. Shen Y. Pardes H. Haloperidol concentrations elevated in Chinese patients Psychiatry Res 12 1984 167 172
39. Price N. Glazer W. Morgenstern H. Race and the use of fluphenazine decanoate Am J Psychiatry 142 1985 1491 1492
40. Reidenberg M. Erill S. Drug-Protein Binding 1986 Oxford University Press New York
41. Routledge P. The plasma protein binding of basic drugs Br J Clin Pharmacol 22 1986 499 506
42. Rudorfer M. Pharmacokinetics of psychotropic drugs in special populations J Clin Psychiatry 54 1993 50 54 (suppl
43. Rutledge D. Steinberg M. Cardozo L. Racial differences in drug response: Isoproterenol effects on heart rate following intravenous metoprolol Clin Pharmacol Ther 45 1989 380 386
44. Sartorius N. The research component of the WHO mental health program Psychol Med 10 1980 175 185
45. Silver B. Lin K. Poland R. Ethnicity and the pharmacology of tricyclic antidepressants Lin K. Poland R. Nakasaki G. Psychopharmacology and Psychobiology of Ethnicity 1993 American Psychiatric Press Washington
46. Sramek J. Sayles M. Simpson G. Neuroleptic dosage for Asians: A failure to replicate Am J Psychiatry 143 1986 535 536
47. Strickland T. Lin K. Fu P. Comparison of lithium ratio variation between African American and Caucasian bipolar patients Biol Psychiatry 37 1995 325 330
48. Strickland T. Ranganath V. Lin K. Psychopharmacologic considerations in the treatment of Black American populations Psychopharmacol Bull 27 1991 441 448
49. Takahashi R. Lithium treatment in affective disorders: Therapeutic plasma level Psychopharmacol Bull 15 1979 32 35
50. Weber W.W. The Acetylator Genes and Drug Responses 1987 Oxford University Press New York
51. Wood A. Zhou H. Ethnic differences in drug disposition and responsiveness Clin Pharmacokinet 20 1991 1 24
52. Zhou H. Adedoyin A. Wilkinson G. Differences in plasma binding of drugs between Caucasians and Chinese subjects Clin Pharmacol Ther 48 1990 10 17
53. Zhou H. Koshakji R. Siolberstein D. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American white New Engl J Med 320 1989 565 570
54. Ziegler V. Biggs J. Tricyclic plasma levels—Effect of age, race, sex, and smoking JAMA 438 1977 2167 2169
55. Zito J. Craig T. Wanderling J. Pharmaco-epidemiology in 136 hospitalized schizophrenic patients Am J Psychiatry 144 1987 778 782